Westpac Banking Corp decreased its stake in shares of Humana Inc. (NYSE:HUM) by 61.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,487 shares of the insurance provider’s stock after selling 59,477 shares during the quarter. Westpac Banking Corp’s holdings in Humana were worth $9,020,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in HUM. Federated Investors Inc. PA raised its holdings in shares of Humana by 608.1% in the 2nd quarter. Federated Investors Inc. PA now owns 34,626 shares of the insurance provider’s stock valued at $8,331,000 after purchasing an additional 29,736 shares in the last quarter. Creative Planning raised its holdings in shares of Humana by 0.3% in the 2nd quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after purchasing an additional 15 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Humana by 15.8% during the 1st quarter. ProShare Advisors LLC now owns 17,297 shares of the insurance provider’s stock worth $3,566,000 after acquiring an additional 2,356 shares in the last quarter. OZ Management LP raised its stake in shares of Humana by 4.9% during the 2nd quarter. OZ Management LP now owns 667,478 shares of the insurance provider’s stock worth $160,608,000 after acquiring an additional 30,927 shares in the last quarter. Finally, US Bancorp DE raised its stake in shares of Humana by 4.4% during the 2nd quarter. US Bancorp DE now owns 44,359 shares of the insurance provider’s stock worth $10,674,000 after acquiring an additional 1,870 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.
HUM has been the subject of several recent analyst reports. Citigroup Inc. initiated coverage on shares of Humana in a research note on Wednesday, June 28th. They set a “buy” rating and a $275.00 price objective for the company. BidaskClub downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $257.00 target price on the stock in a research report on Thursday, May 25th. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research report on Friday, June 9th. Finally, Bank of America Corporation upped their price objective on shares of Humana from $270.00 to $275.00 and gave the company a “buy” rating in a report on Friday, July 14th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. Humana has an average rating of “Buy” and a consensus target price of $244.35.
WARNING: This article was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://ledgergazette.com/2017/09/17/westpac-banking-corp-has-9-02-million-stake-in-humana-inc-hum.html.
Humana Inc. (NYSE HUM) opened at 249.28 on Friday. The stock has a market cap of $36.03 billion, a price-to-earnings ratio of 20.51 and a beta of 0.87. The stock has a 50 day moving average of $250.25 and a 200 day moving average of $231.50. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $259.76.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. During the same period last year, the business earned $2.30 EPS. Equities analysts expect that Humana Inc. will post $11.55 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.06%.
In other Humana news, VP M Todoroff Christopher sold 22,935 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $252.52, for a total value of $5,791,546.20. Following the sale, the vice president now owns 24,001 shares of the company’s stock, valued at approximately $6,060,732.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Bruce D. Broussard sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the sale, the chief executive officer now directly owns 80,086 shares in the company, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. Insiders sold a total of 60,566 shares of company stock worth $15,326,746 over the last three months. 0.80% of the stock is owned by company insiders.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.